Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Munzone E, Gray KP, Fumagalli C, Guerini-Rocco E, Láng I, Ruhstaller T, Gianni L, Kammler R, Viale G, Di Leo A, Coates AS, Gelber RD, Regan MM, Goldhirsch A, Barberis M, Colleoni M. Munzone E, et al. Among authors: goldhirsch a. Breast Cancer Res Treat. 2018 Jul;170(2):351-360. doi: 10.1007/s10549-018-4767-1. Epub 2018 Mar 27. Breast Cancer Res Treat. 2018. PMID: 29589138 Clinical Trial.
Overhauling the breast cancer overview: are subsets subversive?
Coates A, Goldhirsch A, Gelber R; International Breast Cancer Study Group. Coates A, et al. Among authors: goldhirsch a. Lancet Oncol. 2002 Sep;3(9):525-6. doi: 10.1016/s1470-2045(02)00842-2. Lancet Oncol. 2002. PMID: 12217786 No abstract available.
Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L, Curigliano G, Colleoni M, Fazio N, Nole F, Martinelli G, Cinieri S, Graffeo R, Peruzzotti G, Goldhirsch A. Orlando L, et al. Among authors: goldhirsch a. Anticancer Res. 2002 Sep-Oct;22(5):3057-9. Anticancer Res. 2002. PMID: 12530042 Clinical Trial.
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, Coates AS, Collins J, Castiglione-Gertsch M, Gusterson BA; International Breast Cancer Study Group. Trihia H, et al. Among authors: goldhirsch a. Cancer. 2003 Mar 1;97(5):1321-31. doi: 10.1002/cncr.11188. Cancer. 2003. PMID: 12599241 Free article.
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group. Spataro VJ, et al. Among authors: goldhirsch a. Cancer. 2003 Apr 1;97(7):1591-600. doi: 10.1002/cncr.11224. Cancer. 2003. PMID: 12655514 Free article.
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, Veronesi U. Decensi A, et al. Among authors: goldhirsch a. J Natl Cancer Inst. 2003 Jun 4;95(11):779-90. doi: 10.1093/jnci/95.11.779. J Natl Cancer Inst. 2003. PMID: 12783932 Free article. Clinical Trial.
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Crivellari D, Price K, Gelber RD, Castiglione-Gertsch M, Rudenstam CM, Lindtner J, Fey MF, Senn HJ, Coates AS, Collins J, Goldhirsch A; International Breast Cancer Study Group. Crivellari D, et al. Among authors: goldhirsch a. J Clin Oncol. 2003 Dec 15;21(24):4517-23. doi: 10.1200/JCO.2003.03.559. J Clin Oncol. 2003. PMID: 14673038 Clinical Trial.
716 results